Parties d'ouvrages collectifs (5)
  1. 1. Eizirik, D. L., & Hoorens, A. (1999). Beta-cell dysfunction and death. In S. L. Howell (Ed.), Biology of the pancreatic beta-cell (pp. 47-73). Connecticut, USA: JAI Press INC.(Advances in molecular and cell biology, 29).
  2. 2. Sandler, S., & Eizirik, D. L. (1996). Culture of human pancreatic islet cells. In G. D. Jones (Ed.), Human cell culture protocols (pp. 391-4017). Totowa, USA: Humana Press.(Methods in Molecular Medicine, 2).
  3. 3. Eizirik, D. L., Sandler, S., Björklund, A., & Welsh, N. (1994). Possible mechanisms of damage and repair of pancreatic beta-cells in diabetes mellitus. In P. Flatt & S. Lenzen (Eds.), Frontiers of pancreatic beta-cell research (pp. 535-542). London: Smith Gordon and Co. Ldt.
  4. 4. Sandler, S., Eizirik, D. L., Sternesjö, J., & Welsh, N. (1994). Cytokines and islet beta-cell function. In P. Flatt & S. Lenzen (Eds.), Frontiers of pancreatic beta-cell research (pp. 553-558). London: Smith Gordon and Co. Ldt.
  5. 5. Eizirik, D. L., & Hellerström, C. (1993). Structure and function of the normal and diabetic beta-cell. In A. K. Sharma (Ed.), Diabetes mellitus and its complications: an update (pp. 40-50). London: Macmillan International.
    6.   Articles dans des revues avec comité de lecture (406)
  6. 1. Robertson, C. C., Elgamal, R. R., Henry-Kanarek, B. B., Arvan, P., Chen, S., Dhawan, S., Eizirik, D. L., Kaddis, J. J., Vahedi, G., Parker, S. G., Gaulton, K. K., & Soleimanpour, S. S. (2024). Untangling the genetics of beta cell dysfunction and death in type 1 diabetes. Molecular metabolism, 86, 101973. doi:10.1016/j.molmet.2024.101973
  7. 2. Muralidharan, C., Huang, F., Enriquez, J. J., Wang, J. J., Nelson, J. J., Nargis, T., May, S. S., Chakraborty, A., Figatner, K. K., Navitskaya, S., Anderson, C. C., Calvo, V., Surguladze, D., Mulvihill, M. M., Yi, X., Sarkar, S., Oakes, S. S., Webb-Robertson, B. J. B., Sims, E. E., Staschke, K. K., Eizirik, D. L., Nakayasu, E. S., Stokes, M. M., Tersey, S. S., & Mirmira, R. R. (2024). Inhibition of the Eukaryotic Initiation Factor-2-α Kinase PERK Decreases Risk of Autoimmune Diabetes in Mice. The Journal of clinical investigation, 134(12). doi:10.1172/JCI176136
  8. 3. Coomans De Brachene, A., Alvelos, M. I., Szymczak, F., Zimath, P. L., Oliveira Castela, A. S., Marmontel De Souza, B., Roca Rivada, A., Marin Canas, S., Yi, X., Op De Beeck, A., Morgan, N. G., Sonntag, S., Jawurek, S., Title, A. C., Yesildag, B., Pattou, F., Kerr-Conte, J., Montanya, E., Nacher, M., Marselli, L., Marchetti, P., Richardson, S. J., & Eizirik, D. L. (2024). Interferons are key cytokines acting on pancreatic islets in type 1 diabetes. Diabetologia, 67(5), 908-927. doi:10.1007/s00125-024-06106-7
  9. 4. Callebaut, A., Guyer, P., Derua, R., Buitinga, M., Manganaro, A., Yi, X., Sodré, F. M. C., Vig, S., Suleiman, M., Marchetti, P., Eizirik, D. L., Kent, S. S., Mathieu, C., James, E. E., & Overbergh, L. (2024). CD4+ T Cells From Individuals With Type 1 Diabetes Respond to a Novel Class of Deamidated Peptides Formed in Pancreatic Islets. Diabetes, 73(5), 728-742. doi:10.2337/db23-0588
  10. 5. Yang, C., Wang, F. X., Luo, J., Rong, S. J., Lu, W. Y., Chen, Q. J., Xiao, J., Wang, T., Song, D. N., Liu, J., Mo, Q., Li, S., Chen, Y., Wang, Y. N., Liu, Y. J., Yan, T., Gu, W. K., Zhang, S., Xiong, F., Yu, Q., Zhang, Z. Y., Yang, P., Liu, S.-W., Eizirik, D. L., Dong, L. L., Sun, F., & Wang, C. Y. (2024). PDIA3 orchestrates effector T cell program by serving as a chaperone to facilitate the non-canonical nuclear import of STAT1 and PKM2. Molecular therapy. doi:10.1016/j.ymthe.2024.05.038
  11. 6. Zhang, J., Zou, Y., Chen, L., Sun, F., Xu, Q., Zhou, Q., Wang, Y., Luo, X., Wang, N., Li, Y., Zhang, S., Xiong, F., Yang, P., Liu, S.-W., Yang, T., Weng, J., Eizirik, D. L., Yan, J., Zhou, Z., & Wang, C. Y. (2023). Myo9b mutations are associated with altered dendritic cell functions and increased susceptibility to autoimmune diabetes onset. Nature communications, 14(1), 5977. doi:10.1038/s41467-023-41534-w
  12. 7. Cantley, J., Eizirik, D. L., Latres, E., & Dayan, C. C. (2023). Islet cells in human type 1 diabetes: from recent advances to novel therapies - a symposium-based roadmap for future research. The Journal of endocrinology, 259(1). doi:10.1530/JOE-23-0082
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 39 40 41 42 Suivant >>